Navigation Links
Stallergenes : Sublingual Desensitisation Tablets Oralair Grasses Approved in Germany
Date:6/24/2008

ANTONY, France, June 24 /PRNewswire-FirstCall/ -- Today, Stallergenes has been granted with the marketing authorisation for its sublingual desensitisation tablet, Oralair(R) Grasses in adults, by PEI (Paul Ehrlich Institute), the biological branch of the German health agency.

Based on the positive results of the paediatric pivotal study (VO52), Stallergenes will immediately apply for a paediatric extension of the product's indications.

Stallergenes will launch Oralair(R) Grasses in the adult indication on the German market in the coming weeks. The company expects to extend this launch to the paediatric population this year so as to capture the forthcoming prescription period for grass pollen desensitisation in both indications.

Subsequent market authorization in Europe will be applied afterwards through a Mutual Recognition Procedure (MRP) for both indications, Germany being the reference member state.

"The registration of Oralair(R) Grasses in Germany is a significant breakthrough that gives desensitisation treatments the same level of recognition as mainstream pharmaceuticals and creates a new therapeutic class: "the allergens". I am particularly proud of the fact that Stallergenes has succeeded in turning itself into a genuine biopharmaceutical company, capable of developing and registering pharmaceuticals that meet the highest regulatory standards. We expect the Oralair programme to bring in a steady flow of product licenses in the next few years," says Albert Saporta, Chairman and CEO of Stallergenes.

About The Oralair development programme

According to World Health Organisation (WHO) estimates, 20 to 25% of the world's population suffer from respiratory allergic symptoms, rhinitis and/or asthma. By 2020, 50 % of the world's population will be concerned by allergy according to ISAAC study. According to WHO, desensitisation is the only treatment that addresses the immunological cause of allergy and modifies the na
'/>"/>

SOURCE Stallergenes
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3

Related biology technology :

1. STALLERGENES : Strong Business Growth: +17% and Earnings Per Share up 30%
2. Stallergenes : 3rd Quarter Sales Up 17%: 9- Month Cumulative Sales Up 17%
3. STALLERGENES: ORALAIR Grasses: Positive Results of VO52.06 Paediatric Study
4. STALLERGENES and Protein eXpert Enter Into a Partnership for Producing Mites Recombinant Allergens
5. STALLERGENES: 2007: A Further Year of Strong Growth: Up 16%
6. STALLERGENES : Further Profit Growth Acceleration of R&D Expenditure
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Methimazole Tablets USP, 5 mg and 10 mg
8. Dey L.P. and Critical Therapeutics Launch Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release Tablets for the Chronic Treatment of Asthma
9. CV Therapeutics Submits Supplemental New Drug Application for Ranexa(R) (ranolazine extended-release tablets)
10. Barr Receives Approval for Generic Combunox(R) Tablets, 5mg/400mg
11. Mylan Announces Tentative FDA Approval for Lamotrigine Tablets

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... PARIS, November 27 ... market Oralair(R) in both adults and children,thr...first country where,Oralair(R) has been marketed, ...(R) is now registered in Austria, Belgium, Bulgari...rmany, Greece, Hungary, Ireland, Italy,Latvia, Li...
(Date:11/26/2009)...LAFAYETTE, Ind. - A new generation of ultrasmall t...tiny structures called semiconducting nanowires ar...rchers at IBM, Purdue University and the Universit...s have learned how to create nanowires with layers...t the atomic level, which is a critical requiremen...
(Date:11/25/2009)... , BOSTON, Nov. 25 Biotech fir...s, genomic data from the 1918 pandemic through the... H1N1 pandemic, today issued its latest biochemica...he lethality of the H1N1 ("Swine Flu") virus has d...virus,s current outbreak in the spring of 2009 to ...
(Date:11/25/2009)... , ,, BOCA RATON, Fla., Nov. ...een a painful year. Not so for BodyLogicMD. The n...ert physicians specializing exclusively in medical...he number of physicians in its network since...s in progress to add more physician-owned centers,...
Breaking Biology Technology:STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 2STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 3Nanowires key to future transistors, electronics 2Nanowires key to future transistors, electronics 3Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 4
...dia Site Live allows WVU to stream video from thei...an watch their classes from a computer at their co...l courses will be available on the web beginning t...need more nurse educators to teach the next genera...f nursing at WVU School of Nursing. By using Media...
...t only does WisconsinGuide.com save time, it has a...terson said that the site is a great example of re...to bring the real time economy to the traditional ...ners the ability to quickly, easily and affordably...nsinGuide.com was featured on the WMTV NBC 15 morn...
...e controversial May edition of the Harvard Busine... Nicholas Carr entitled IT Doesn,t Matter , questi...d a stir in the business and technology communitie... Marketing , a small company based in Appleton whi...d uses technology to impact the sales, marketing a...
Other Biology Technology:Sonic Foundry Facilitates Nursing Education 2Sonic Foundry Facilitates Nursing Education 3Wisconsin Tourism Aided by Internet Technology 2Wisconsin Tourism Aided by Internet Technology 3IT Does Matter! 2IT Does Matter! 3
(Date:11/26/2009)...countries has shown that closing schools in the ev... significant role in reducing illness transmission...BMC Infectious Diseases compared opportunities fo...finding that they were reduced when schools are sh...sity, Belgium, led a team of European researchers ...
(Date:11/26/2009)...ccus Aureus ) and other drug-resistant bacteria co...ototype devices have been developed to offer safe,... , Two prototype devices have been developed: on... hands and feet) in hospitals and public spaces wh... to shoot bacteria-killing agents into infested ch...
(Date:11/25/2009)...ives. In addition to mammalian immune systems that...d bacteriophages, viruses that kill half the bacte...and another class of microorganisms called archaea... deep-sea volcanic vents) manage just fine, thank ...system that helps protect them from many viruses a...
Breaking Biology News(10 mins):School closure could reduce swine flu transmission by 21 percent 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3Ventilation After Breathing Tube Removal May Alter Outcomes 54416 1Ventilation After Breathing Tube Removal May Alter Outcomes 54416 2MRI May Not Improve Breast Cancer Outcome 54414 1China Medicine Announces Second Quarter 2009 Results 54412 1China Medicine Announces Second Quarter 2009 Results 54412 2China Medicine Announces Second Quarter 2009 Results 54412 3China Medicine Announces Second Quarter 2009 Results 54412 4China Medicine Announces Second Quarter 2009 Results 54412 5China Medicine Announces Second Quarter 2009 Results 54412 6China Medicine Announces Second Quarter 2009 Results 54412 7China Medicine Announces Second Quarter 2009 Results 54412 8China Medicine Announces Second Quarter 2009 Results 54412 9China Medicine Announces Second Quarter 2009 Results 54412 10China Medicine Announces Second Quarter 2009 Results 54412 11China Medicine Announces Second Quarter 2009 Results 54412 12China Medicine Announces Second Quarter 2009 Results 54412 13China Medicine Announces Second Quarter 2009 Results 54412 14
...lcohol spectrum disorder (FASD) and Fetal alcohol ...uding facial defects, short stature, and mental an...pus, is a valuable tool for understanding early ve..., easy to work with and very responsive to environ...ress the mechanism underlying the characteristics ...
...re,s Institute of Bioengineering and Nanotechnolog...oporous material using a unique surfactant templat... been predicted only mathematically (see reference... reference below), the IBN scientists report that ...h institute, is the first hexagonal nanoscale cons...
...LPHIA - A collaboration of University of Pennsylva...hesiologists have identified a fluorescent anesthe...ning more precise information about how anesthetic...e rapidly test new anesthetic compounds in the sea...dy is published online in the Proceedings of the ...
Other Biology News:Frogs reveal clues about the effects of alcohol during development 2First tri-continuous mesoporous Silica complex structure developed in Singapore 2Penn researchers demonstrate a new model for drug discovery with a fluorescent anesthetic 2Penn researchers demonstrate a new model for drug discovery with a fluorescent anesthetic 3
Rabbit Anti-GRASP1 Polyclonal Antibody, Unconjugated from Abcam
Porcine Galanin , 3-[125I]iodotyrosyl26 Conjugated/Tagged from GE Healthcare, formerly Amersham Biosciences
Rabbit Anti-CRIPT Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Rabbit Anti-HES1 Antibody, Unconjugated from ABR-Affinity BioReagents
Biology Products: